Original research

Effects of recombinant human growth hormone on HIV-1-specific T-cell responses, thymic output and proviral DNA in patients on HAART: 48-week follow-up

Anna A Herasimtschuk¹, Samantha J Westrop¹, Graeme J Moyle², Jocelyn S Downey¹ and Nesrina Imami¹^*

¹ Department of Immunology, Imperial College London, Chelsea and Westminster Hospital, 369 Fulham Road, London, SW10 9NH, UK

² Department of HIV/GU Medicine, Imperial College London, Chelsea and Westminster Hospital, 369 Fulham Road, London, SW10 9NH, UK

For all author emails, please log on.

Journal of Immune Based Therapies and Vaccines 2008, 6:7 doi:10.1186/1476-8518-6-7

Published: 31 October 2008

Additional file 1:

Table 1. Patient characteristics at baseline (week 0), and weeks 12, 24 and 48 of the study.

Format: DOC Size: 75KB Download file

This file can be viewed with: Microsoft Word Viewer